Baxter International Inc. has announced a $50 million expansion of its sterile fill/finish manufacturing facilities located in Bloomington, IN. These facilities are operated by Baxter’s BioPharma Solutions business, a contract manufacturing organization that specializes in parenteral (injectable) pharmaceuticals. The expansion is being funded by a combination of Baxter and client investment. Additional details of the agreement were not disclosed.   The planned expansion of existing facility infr...